Related Experiment Videos
The application of official policy. Prophylaxis recommendations for patients with mitral valve prolapse
Abstract:
In 1977, the American Heart Association recommended that patients with mitral valve prolapse (MVP) and mitral insufficiency receive antibiotic prophylaxis prior to procedures that place them at risk for bacterial endocarditis. To study how clinicians conformed to this recommendation, the authors selected 126 patients with MVP admitted to a University Medical Center in 1978, the year following the official policy. Overall, only 47 patients (37%) had the antibiotic prophylaxis recommended. Furthermore, information that might have increased the certainty of diagnosis of MVP or the likelihood of mitral insufficiency did not influence the physician's decision: symptoms, previous history, procedures, sex, evidence for mitral insufficiency, other serious illnesses, or the use of cardiac medications. However, patients seen in consultation by a cardiologist were much more likely to have prophylaxis recommended (P less than 0.05). It was concluded that the application of an official policy about prophylaxis for a condition such as MVP, where the risks are uncertain, is likely to be guided by other factors, such as the opinions of local experts.
Insights
Few patients with mitral valve prolapse (MVP) received recommended antibiotic prophylaxis. Physician decisions were influenced by cardiologist consultation, not patient factors, highlighting the impact of expert opinion on guideline implementation.
Area of Science:
- Cardiology
- Infectious Disease Prevention
- Clinical Practice Guidelines
Background:
- The American Heart Association issued guidelines in 1977 for antibiotic prophylaxis in patients with mitral valve prolapse (MVP) and mitral insufficiency.
- Bacterial endocarditis prevention is crucial for at-risk cardiac patients.
Purpose of the Study:
- To assess clinician adherence to the 1977 antibiotic prophylaxis recommendation for MVP patients.
- To identify factors influencing the prescription of prophylaxis.
Main Methods:
- A retrospective review of 126 patients diagnosed with MVP admitted to a University Medical Center in 1978.
- Analysis of patient records to determine if antibiotic prophylaxis was recommended.
Main Results:
- Only 37% of patients with MVP received the recommended antibiotic prophylaxis.
- Physician decisions were not influenced by patient symptoms, history, sex, or comorbidities.
- Consultation with a cardiologist significantly increased the likelihood of prophylaxis recommendation (P < 0.05).
Conclusions:
- Adherence to official clinical policies for MVP prophylaxis is inconsistent.
- The implementation of guidelines for conditions with uncertain risks may be driven by local expert opinions rather than strict adherence to policy.